Clinical trials
Completed Musculoskeletal Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
411 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 6 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 13 |
| 2010 | 4 |
| 2011 | 10 |
| 2012 | 10 |
| 2013 | 18 |
| 2014 | 23 |
| 2015 | 20 |
| 2016 | 22 |
| 2017 | 28 |
| 2018 | 37 |
| 2019 | 27 |
| 2020 | 25 |
| 2021 | 45 |
| 2022 | 33 |
| 2023 | 30 |
| 2024 | 20 |
| 2025 | 15 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 411 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 12 |
| National Research Centre for the Working Environment, Denmark | 11 |
| Afyonkarahisar Health Sciences University | 8 |
| Amgen | 5 |
| Chinese University of Hong Kong | 5 |
| I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | 5 |
| University of Pittsburgh | 5 |
| Regeneron Pharmaceuticals | 4 |
| Rigshospitalet, Denmark | 4 |
| Vanderbilt University Medical Center | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Musculoskeletal Diseases | 411 |
| Joint Diseases | 60 |
| Arthritis | 45 |
| Osteoarthritis | 33 |
| Rheumatic Diseases | 30 |
| Pain | 24 |
| Osteoarthritis, Knee | 22 |
| Bone Diseases | 21 |
| Nervous System Diseases | 19 |
| Arthritis, Rheumatoid | 18 |
Trials
Showing 76 to 100 of 411. Each trial links to its page on Pharma Observatory.
311 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.